Meta is offering monthly guaranteed pay and boosted reach for creators to start posting on Facebook's Reels.

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

For years, identity has been treated as the foundation of workforce security. If an organization could reliably confirm who a user was, the assumption followed that access could be granted with ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Forbes contributors publish independent expert analyses and insights. Non-fungible tokens have transformed the art world, offering artists innovative ways to create, sell and profit from their digital ...